137 related articles for article (PubMed ID: 37467738)
1. Potential Cost Savings by Switching from Subcutaneous to Intralymphatic Insect Venom Immunotherapy.
Chabot A; Lang C; Kündig TM; Schmid-Grendelmeier P; Johansen P
Int Arch Allergy Immunol; 2023; 184(10):985-993. PubMed ID: 37467738
[TBL] [Abstract][Full Text] [Related]
2. Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in Humans.
Chabot A; Senti G; Erdmann I; Prinz BM; Wüthrich B; Šošić L; Kündig TM; Johansen P
Front Allergy; 2022; 3():832010. PubMed ID: 35386649
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Safety, Efficacy, and Compliance of Intralymphatic Immunotherapy for Allergic Rhinoconjunctivitis: A Systematic Review and Meta-Analysis.
Wang W; Wang X; Wang H; Wang X
Int Arch Allergy Immunol; 2023; 184(8):754-766. PubMed ID: 37105134
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in allergic rhinitis patients treated with intralymphatic immunotherapy (ILIT): A 19-year follow-up.
Adlany YK; Šošić L; Senti G; Lang CCV; Wüthrich B; Kündig TM; Johansen P
J Allergy Clin Immunol Glob; 2023 Feb; 2(1):43-50. PubMed ID: 37780115
[TBL] [Abstract][Full Text] [Related]
5. Intralymphatic immunotherapy.
Senti G; Johansen P; Kündig TM
Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):537-43. PubMed ID: 19680119
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of short-term combination of intralymphatic allergen immunotherapy and lokivetmab treatment in canine atopic dermatitis: A double-blinded, controlled, randomised study.
van Amersfort K; Vernooij JCM; van der Lee A
Vet Dermatol; 2023 Oct; 34(5):373-384. PubMed ID: 37186491
[TBL] [Abstract][Full Text] [Related]
7. Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview.
Asaria M; Dhami S; van Ree R; Gerth van Wijk R; Muraro A; Roberts G; Sheikh A
Allergy; 2018 Feb; 73(2):269-283. PubMed ID: 28718981
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and safety of cervical intralymphatic immunotherapy for house dust mite allergic rhinitis: A pilot study.
Wang K; Zheng R; Chen Y; Yu Q; Zhong H; Xiao P; Wang Y; Tang J
Am J Otolaryngol; 2019; 40(6):102280. PubMed ID: 31519431
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of subcutaneous, intralymphatic and sublingual immunotherapy for the long-term control of dogs with nonseasonal atopic dermatitis.
Fischer NM; Rostaher A; Favrot C
Vet Dermatol; 2020 Oct; 31(5):365-e96. PubMed ID: 32537789
[TBL] [Abstract][Full Text] [Related]
10. A Pilot Study of Intralymphatic Immunotherapy for House Dust Mite, Cat, and Dog Allergies.
Lee SP; Choi SJ; Joe E; Lee SM; Lee MW; Shim JW; Kim YJ; Kyung SY; Park JW; Jeong SH; Jung JH
Allergy Asthma Immunol Res; 2017 May; 9(3):272-277. PubMed ID: 28293934
[TBL] [Abstract][Full Text] [Related]
11. A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy.
Weinfeld D; Westin U; Hellkvist L; Mellqvist UH; Jacobsson I; Cardell LO
Allergy Asthma Clin Immunol; 2020; 16():31. PubMed ID: 32368217
[TBL] [Abstract][Full Text] [Related]
12. Intralymphatic Immunotherapy: Update and Unmet Needs.
Senti G; Freiburghaus AU; Larenas-Linnemann D; Hoffmann HJ; Patterson AM; Klimek L; Di Bona D; Pfaar O; Ahlbeck L; Akdis M; Weinfeld D; Contreras-Verduzco FA; Pedroza-Melendez A; Skaarup SH; Lee SM; Cardell LO; Schmid JM; Westin U; Dollner R; Kündig TM
Int Arch Allergy Immunol; 2019; 178(2):141-149. PubMed ID: 30391954
[TBL] [Abstract][Full Text] [Related]
13. New directions in immunotherapy.
Cox L; Compalati E; Kundig T; Larche M
Curr Allergy Asthma Rep; 2013 Apr; 13(2):178-95. PubMed ID: 23315329
[TBL] [Abstract][Full Text] [Related]
14. Intralymphatic immunotherapy improves grass pollen allergic rhinoconjunctivitis: A 3-year randomized placebo-controlled trial.
Skaarup SH; Schmid JM; Skjold T; Graumann O; Hoffmann HJ
J Allergy Clin Immunol; 2021 Mar; 147(3):1011-1019. PubMed ID: 32679209
[TBL] [Abstract][Full Text] [Related]
15. Novel strategies for the treatment of grass pollen-induced allergic rhinitis.
Larsson O; Hellkvist L; Peterson-Westin U; Cardell LO
Expert Opin Biol Ther; 2016 Sep; 16(9):1143-50. PubMed ID: 27269991
[TBL] [Abstract][Full Text] [Related]
16. Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.
Hylander T; Larsson O; Petersson-Westin U; Eriksson M; Kumlien Georén S; Winqvist O; Cardell LO
Respir Res; 2016 Jan; 17():10. PubMed ID: 26817454
[TBL] [Abstract][Full Text] [Related]
17. [Research progress on intralymphatic immunotherapy].
Rong LJ; Zheng J; Lang JQ; Meng CD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Aug; 53(8):628-630. PubMed ID: 30122005
[TBL] [Abstract][Full Text] [Related]
18. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
Hylander T; Latif L; Petersson-Westin U; Cardell LO
J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy.
Hockenhull J; Elremeli M; Cherry MG; Mahon J; Lai M; Darroch J; Oyee J; Boland A; Dickson R; Dundar Y; Boyle R
Health Technol Assess; 2012; 16(12):III-IV, 1-110. PubMed ID: 22409877
[TBL] [Abstract][Full Text] [Related]
20. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections.
Senti G; Crameri R; Kuster D; Johansen P; Martinez-Gomez JM; Graf N; Steiner M; Hothorn LA; Grönlund H; Tivig C; Zaleska A; Soyer O; van Hage M; Akdis CA; Akdis M; Rose H; Kündig TM
J Allergy Clin Immunol; 2012 May; 129(5):1290-6. PubMed ID: 22464647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
